ArticleCell reports. Medicine2024

A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer.

Nasser K Altorki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.